Open-Label Extension Trial of PDE4 Inhibition With Roflumilast for the Management of Plaque Psoriasis

Condition:   Chronic Plaque Psoriasis Intervention:   Drug: Topical roflumilast Sponsor:   Arcutis Biotherapeutics, Inc. Enrolling by invitation

Source: ClinicalTrials.gov - February 27, 2020 Category: Research Source Type: clinical trials